Finance Expert

Finance Expert

Trump threatens Apple with 25% tariff and EU with 50% starting next week

Finance Expert

The delusion of private equity IRRs

Ludovic Phalippou is professor of financial economics at the University of Oxford’s Saïd Business School. A decade ago, Steven Davidoff Solomon, a UC Berkeley corporate law professor, published in the…

Finance Expert

Here’s why GameStop’s stock has been in play again. It’s not a meme thing this time.

Shares of videogame retailer and original meme stock GameStop are riding the bitcoin wave.

Finance Expert

Why Oscar Health, Inc. (OSCR) Crashed Today

We recently published a list of 10 Firms Drenched in Red Today. In this article, we are going to take a look at where Oscar Health, Inc. (NYSE:OSCR) stands against other…

Finance Expert

Mullen Group prices C$400M senior notes (MTL:CA:TSX)

Mullen Group (TSX:MTL:CA) priced an approximately CAD$400M aggregate principal amount senior secured notes offering, by way of a private placement. The senior secured notes will be guaranteed by Mullen Group's…

Finance Expert

Benjamin Netanyahu lashes out at western allies over Gaza ceasefire calls

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Benjamin Netanyahu has lashed out at UK Prime Minister Sir…

Finance Expert

Top Chinese drugmaker Hengrui soars in Hong Kong trading debut

Hengrui’s debut, which comes on the heels of CATL’s blockbuster Hong Kong premiere, builds on Hong Kong’s hot listings market—where proceeds are forecast to double to more than $22 billion…

Finance Expert

FTAV’s further reading

Optimal onion-slicing; NYC tycoons; perfect soy sauce; Trump Inc

Finance Expert

The stock market is seeing more ‘90% days.’ Here’s what that means for your money.

Volatility favors the bulls for now, with the S&P 500’s upside target near 6,150.

Finance Expert

BofA Reiterates Hold Rating on Novavax (NVAX) Stock

On May 20, BofA analyst Alec Stranahan reiterated a Hold rating on Novavax, Inc. (NASDAQ:NVAX) stock, setting a price target of $10. The approval of Nuvaxovid for use in older…